A groundbreaking clinical study will utilise Optiscan’s InVue microscopic precision surgery device, as well as its InForm digital...

Optiscan Imaging has inked a collaborative deal with US-based Long Grove Pharmaceuticals to trial the drugmaker’s AK-FLUOR fluorescein...

Optiscan Imaging has unveiled its high-tech imaging device InSpecta, designed for veterinarians to boost diagnostics and treatment for pets, including dogs and cats.

Optiscan Imaging has successfully beta-tested its cloud telepathology platform, allowing remote, real-time digital diagnostics using...

Optiscan Imaging is working with the Mayo Clinic to jointly develop an imaging system suitable for use with robotic surgery. Optiscan...

This just might be a medical revolution – no more agonising waits for pathology results!

Optiscan Imaging’s newly launched InForm diagnostic imaging device aims to bring digital technology into the pathology industry. Optiscan...

Optiscan Imaging has kicked off pre-clinical trials of its second-generation endomicroscope to test real-time imaging of the...

With 12 million pets diagnosed with cancer annually, Optiscan (ASX: OIL) and the University of Minnesota Veterinary faculty have inked a...

ASX-listed medical technology company Optiscan Imaging (ASX: OIL) has locked in a partnership deal with Monash University to help...

Innovative medical device company Optiscan Imaging (ASX: OIL) doubled revenues and tabled its first significant quarterly cash profit...

ASX-listed medical device company Optiscan Imaging (ASX: OIL) has ramped-up its efforts to capture the lucrative US healthcare market by...

Optiscan Imaging (ASX: OIL) is moving into veterinary medicine through a memorandum of understanding (MoU) with the United States-based...

Optiscan Imaging (ASX: OIL) has developed a cloud-based platform for the remote diagnosis of cancer using its remarkable medical imaging...

Optiscan Imaging (ASX: OIL) has received the nod of approval from the Royal Melbourne Hospital to start taking real-time in-human images...

No more biopsies? – a serious revolution in medical science

ASX-listed Optiscan Imaging (ASX: OIL) has unveiled its latest next-generation microscopic medical imaging device, with its new “InVue”...

Leading WA businessman and thoroughbred horse racing identity Bob Peters with his eighth Perth Cup winner, Star Exhibit. Credit: Danella Bevis/The West Australian Bob Peters is used to backing winners – in fact he has bred and owned a great many of them on his way to becoming the king of WA horse racing. Peters, a shrewd WA businessman who built his fortune selling cars, has won WA’s most iconic thoroughbred horse race – the Perth Cup – a record-breaking 11 times. In fact, at

Optiscan and US-based Mayo Clinic have taken a joint step into the world of robotics in a bid to co-develop digital laser technology for use

Optiscan Imaging’s micro-imaging and photography and related devices and software are revolutionising clinical diagnoses Credit: File Optiscan Imaging (ASX: OIL) says its latest financial results are just the tip of the iceberg, confident a stronger staff presence in the lucrative United States health market will soon reap the rewards for its revolutionary medical devices. The company says its interest in its “ViewnVivo” life sciences product is steadily growing since it esta